Immune Cells in the Normal Ovary and Spontaneous Ovarian Tumors in the Laying Hen (Gallus domesticus) Model of Human Ovarian Cancer

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Bradaric, Michael J ^a,c   Penumatsa, Krishna ^a   Barua, Animesh ^a   Edassery, Seby L ^a   Yu, Yi ^a,d   Abramowicz, Jacques S ^a,e   Bahr, Janice M ^b   Luborsky, Judith L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c CHICAGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CANCER GROWTH; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR DISTRIBUTION; CHICKEN; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; GENE MUTATION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MORPHOMETRICS; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ADENOCARCINOMA, MUCINOUS; ANIMALS; B-LYMPHOCYTES; CARCINOMA, ACINAR CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY;

EID: 84883650671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074147     Document Type: Article

References (68)

1. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A, (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
2. McKenna ES, Roberts CW, (2009) Epigenetics and cancer without genomic instability. Cell Cycle 8: 23-26.
3. Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, et al. (2009) Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol 22: 393-402.
4. Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, Ten Hoor KA, et al. (2008) Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 58: 449-459.
5. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
6. Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, et al. (2009) Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE 4: e6412.
7. de Visser KE, (2008) Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both? Cancer Immunol Immunother 57: 1531-1539.
8. Vanderhyden BC, Shaw TJ, Ethier JF, (2003) Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67.
9. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, et al. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11: 63-70.
10. Quinn BA, Xiao F, Bickel L, Martin L, Hua X, et al. (2010) Development of a syngeneic mouse model of epithelial ovarian cancer. J Ovarian Res 3: 24.
11. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, et al. (2004) A genetically defined model for human ovarian cancer. Cancer Res 64: 1655-1663.
12. Stakleff KD, Von Gruenigen VE, (2003) Rodent models for ovarian cancer research. Int J Gynecol Cancer 13: 405-412.
13. Fredrickson TN, (1987) Ovarian tumors of the hen. Environ Health Perspect 73: 35-51.
14. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19: 531-539.
15. Giles JR, Elkin RG, Trevino LS, Urick ME, Ramachandran R, et al. (2010) The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer. Int J Gynecol Cancer 20: 738-744.
16. Giles JR, Olson LM, Johnson PA, (2006) Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 231: 1718-1725.
17. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE, (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81: 373-379.
18. Johnson PA, Giles JR, (2006) Use of genetic strains of chickens in studies of ovarian cancer. Poult Sci 85: 246-250.
19. Barua A, Abramowicz JS, Bahr JM, Bitterman P, Dirks A, et al. (2007) Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J Ultrasound Med 26: 909-919.
20. Barua A, Bitterman P, Bahr JM, Bradaric MJ, Hales DB, et al. (2010) Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer. J Ultrasound Med 29: 173-182.
21. Barua A, Bitterman P, Bahr JM, Basu S, Sheiner E, et al. (2011) Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model. J Ultrasound Med 30: 333-345.
22. Gonzalez Bosquet J, Peedicayil A, Maguire J, Chien J, Rodriguez GC, et al. (2010) Comparison of gene expression patterns between avian and human ovarian cancers. Gynecol Oncol 120: 256-264.
23. Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, et al. (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila Pa) 2: 114-121.
24. Seo HW, Rengaraj D, Choi JW, Park KJ, Song G, et al. (2010) The expression profile of apoptosis-related genes in the chicken as a human epithelial ovarian cancer model. Oncol Rep 25: 49-56.
25. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE, (2006) CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104: 192-198.
26. Yu Y, Edassery SL, Barua A, Abramowicz JS, Bahr JM, et al. (2011) The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors. J Ovarian Res 4: 12.
27. Urick ME, Johnson PA, (2006) Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 103: 673-678.
28. Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, et al. (2008) Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine 33: 235-244.
29. Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, et al. (2008) Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 109: 115-121.
30. Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, et al. (2009) E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 113: 362-369.
31. Urick ME, Giles JR, Johnson PA, (2008) VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol Oncol 110: 418-424.
32. Urick ME, Giles JR, Johnson PA, (2009) Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecol Oncol 112: 166-170.
33. Barnes MN, Berry WD, Straughn JM, Kirby TO, Leath CA, et al. (2002) A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol Oncol 87: 57-63.
34. Cooper MD, Peterson RD, Good RA, (1965) Delineation of the Thymic and Bursal Lymphoid Systems in the Chicken. Nature 205: 143-146.
35. Barua A, Yoshimura Y, Tamura T, (1998) The effects of age and sex steroids on the macrophage population in the ovary of the chicken, Gallus domesticus. J Reprod Fertil 114: 253-258.
36. Barua A, Yoshimura Y, Tamura T, (1998) Localization of macrophages in the ovarian follicles during the follicular growth and postovulatory regression in chicken, Gallus domesticus. Poult Sci 77: 1417-1421.
37. Barua A, Yoshimura Y, Tamura T, (1998) Effects of ageing and oestrogen on the localization of immunoglobulin-containing cells in the chicken ovary. J Reprod Fertil 114: 11-16.
38. Barua A, Yoshimura Y, (1999) Effects of aging and sex steroids on the localization of T cell subsets in the ovary of chicken, Gallus domesticus. Gen Comp Endocrinol 114: 28-35.
39. Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, et al. (2009) Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer 19: 500-507.
40. Barua A, Bradaric MJ, Kebede T, Espionosa S, Edassery SL, et al. (2007) Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Am J Reprod Immunol 57: 243-249.
41. Gnjatic S, Ritter E, Buchler MW, Giese NA, Brors B, et al. (2010) Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A 107: 5088-5093.
42. Taylor DD, Gercel-Taylor C, Parker LP, (2009) Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 115: 112-120.
43. Cheeseman JH, Kaiser MG, Lamont SJ, (2004) Genetic line effect on peripheral blood leukocyte cell surface marker expression in chickens. Poult Sci 83: 911-916.
44. Gupta SK, Gilbert AB, Walker MA, (1988) Histological study of follicular atresia in the ovary of the domestic hen (Gallus domesticus). J Reprod Fertil 82: 219-225.
45. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, et al. (1998) Leukocytes in normal-cycling human ovaries: immunohistochemical distribution and characterization. Hum Reprod 13: 2186-2191.
46. Barua A, Michiue H, Yoshimura Y, (2001) Changes in the localization of MHC class II positive cells in hen ovarian follicles during the processes of follicular growth, postovulatory regression and atresia. Reproduction 121: 953-957.
47. Oakley OR, Kim H, El-Amouri I, Lin PC, Cho J, et al. (2010) Periovulatory leukocyte infiltration in the rat ovary. Endocrinology 151: 4551-4559.
48. Bukulmez O, Arici A, (2000) Leukocytes in ovarian function. Hum Reprod Update 6: 1-15.
49. Tregaskes CA, Bumstead N, Davison TF, Young JR, (1996) Chicken B-cell marker chB6 (Bu-1) is a highly glycosylated protein of unique structure. Immunogenetics 44: 212-217.
50. Negus RP, Stamp GW, Hadley J, Balkwill FR, (1997) Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150: 1723-1734.
51. Lowe KA, Shah C, Wallace E, Anderson G, Paley P, et al. (2008) Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 17: 2480-2487.
52. Torres MP, Ponnusamy MP, Lakshmanan I, Batra SK, (2009) Immunopathogenesis of ovarian cancer. Minerva Med 100: 385-400.
53. Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, et al. (2006) Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest 35: 251-277.
54. Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, et al. (2006) Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213: 131-145.
55. Papadopoulos N, Kotini A, Cheva A, Jivannakis T, Manavis J, et al. (2002) Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients. Eur J Gynaecol Oncol 23: 533-536.
56. Tomsova M, Melichar B, Sedlakova I, Steiner I, (2008) Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 108: 415-420.
57. Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, et al. (2008) Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol 109: 215-219.
58. Wilke CM, Kryczek I, Zou W, (2011) Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer. Int Rev Immunol 30: 120-126.
59. Dong HP, Elstrand MB, Holth A, Silins I, Berner A, et al. (2006) NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 125: 451-458.
60. Connolly DC, (2009) Animal models of ovarian cancer. Cancer Treat Res 149: 353-391.
61. Bahr JM, Johnson AL, (1984) Regulation of the follicular hierarchy and ovulation. J Exp Zool 232: 495-500.
62. Erf GF, (2004) Cell-mediated immunity in poultry. Poult Sci 83: 580-590.
63. Davison TF, (2003) The immunologists' debt to the chicken. Br Poult Sci 44: 6-21.
64. Kaufman J, Jacob J, Shaw I, Walker B, Milne S, et al. (1999) Gene organisation determines evolution of function in the chicken MHC. Immunol Rev 167: 101-117.
65. Kaufman J, Milne S, Gobel TW, Walker BA, Jacob JP, et al. (1999) The chicken B locus is a minimal essential major histocompatibility complex. Nature 401: 923-925.
66. Ratcliffe MJ, (2006) Antibodies, immunoglobulin genes and the bursa of Fabricius in chicken B cell development. Dev Comp Immunol 30: 101-118.
67. Reynaud CA, Dahan A, Anquez V, Weill JC, (1989) Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell 59: 171-183.
68. McCormack WT, Tjoelker LW, Thompson CB, (1991) Avian B-cell development: generation of an immunoglobulin repertoire by gene conversion. Annu Rev Immunol 9: 219-241.